Ramiro Ribeiro's most recent trade in EyePoint Pharmaceuticals Inc was a trade of 2,438 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| EyePoint Pharma Inc | Ramiro Ribeiro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 2,438 | 82,875 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Ramiro Ribeiro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.26 per share. | 04 Mar 2026 | 2,438 | 2,438 (0%) | 0% | 8.3 | 20,138 | Common Stock |
| EyePoint Pharma Inc | Ramiro Ribeiro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.87 per share. | 04 Mar 2026 | 2,438 | 0 (0%) | 0% | 17.9 | 43,572 | Common Stock |
| EyePoint Pharma Inc | Ramiro Ribeiro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2026 | 2,437 | 85,313 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Ramiro Ribeiro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.26 per share. | 17 Feb 2026 | 2,437 | 2,437 (0%) | 0% | 8.3 | 20,130 | Common Stock |
| EyePoint Pharma Inc | Ramiro Ribeiro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 17 Feb 2026 | 2,437 | 0 (0%) | 0% | 15 | 36,555 | Common Stock |
| EyePoint Pharma Inc | Ramiro Ribeiro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.10 per share. | 05 Jan 2026 | 42,544 | 0 (0%) | 0% | 17.1 | 727,319 | Common Stock |
| EyePoint Pharma Inc | Ramiro Ribeiro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.26 per share. | 05 Jan 2026 | 29,250 | 42,544 (0%) | 0% | 8.3 | 241,605 | Common Stock |
| EyePoint Pharma Inc | Ramiro Ribeiro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2026 | 29,250 | 87,750 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Ramiro Ribeiro | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 171,400 | 171,400 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Ramiro Ribeiro | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 85,700 | 85,700 | - | - | Restricted Stock Units | |
| EyePoint Pharma Inc | Ramiro Ribeiro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2026 | 19,667 | 39,333 | - | - | Restricted Stock Units | |
| EyePoint Pharma Inc | Ramiro Ribeiro | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2026 | 19,667 | 19,667 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharma Inc | Ramiro Ribeiro | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.48 per share. | 02 Jan 2026 | 6,373 | 13,294 (0%) | 0% | 17.5 | 111,400 | Common Stock |
| EyePoint Pharma Inc | Ramiro Ribeiro | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.61 per share. | 11 Nov 2025 | 2,722 | 0 (0%) | 0% | 11.6 | 31,602 | Common Stock |
| EyePoint Pharma Inc | Ramiro Ribeiro | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 117,000 | 117,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Ramiro Ribeiro | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 59,000 | 59,000 | - | - | Restricted Stock Units | |
| EyePoint Pharma Inc | Ramiro Ribeiro | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) |